S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

CVKD Cadrenal Therapeutics Inc

0.4897

-0.0073 (-1.47%)

Last Updated: 01:26:12

Delayed by 15 minutes

Form ARS - Annual Report to Security Holders

Cadrenal Therapeutics (NASDAQ:CVKD)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Cadrenal Therapeutics Charts.

Cadrenal Therapeutics (NASDAQ:CVKD)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Cadrenal Therapeutics Charts.

Cadrenal Therapeutics Inc News

Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance of Anticoagulation Quality in LVAD Patients
Monday 3 June 2024 (1 day ago) • PR Newswire (US)

Form PRE 14A - Other preliminary proxy statements
Thursday 30 May 2024 (6 days ago) • Edgar (US Regulatory)

Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
Thursday 23 May 2024 (2 weeks ago) • PR Newswire (US)

Cadrenal Therapeutics Provides First Quarter 2024 Corporate Update
Thursday 9 May 2024 (4 weeks ago) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 9 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Cadrenal Therapeutics to Participate in Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 18, 2024
Friday 12 April 2024 (2 months ago) • PR Newswire (US)

Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and Thrombosis in Patients with LVADs, RVADs, Biventricular Assist Devices, and Total Artificial Hearts
Tuesday 9 April 2024 (2 months ago) • PR Newswire (US)

Form 8-K - Current report
Tuesday 12 March 2024 (3 months ago) • Edgar (US Regulatory)

Cadrenal Therapeutics Provides Fourth Quarter 2023 Corporate Update
Tuesday 12 March 2024 (3 months ago) • PR Newswire (US)

Form 8-K - Current report
Wednesday 6 March 2024 (3 months ago) • Edgar (US Regulatory)

Cadrenal Therapeutics to Participate at Technology and Heart Failure Therapeutics (THT) Conference
Tuesday 27 February 2024 (3 months ago) • PR Newswire (US)

Form 8-K/A - Current report: [Amend]
Friday 16 February 2024 (4 months ago) • Edgar (US Regulatory)

More Cadrenal Therapeutics Inc News Articles

Pinetree Capital

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions